Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

New York, USA, May 21, 2026 (GLOBE NEWSWIRE) -- Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The...
May 20, 2026 13:00 ET | Source: DelveInsight Business Research LLP

ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight

New York, USA, May 20, 2026 (GLOBE NEWSWIRE) -- ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of...
May 19, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

New York, USA, May 19, 2026 (GLOBE NEWSWIRE) -- Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The...
May 18, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight

New York, USA, May 18, 2026 (GLOBE NEWSWIRE) -- Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals |...
May 14, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight

New York, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight The oligonucleotides...
May 14, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

New York, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight The cervical cancer diagnostics market is...
May 13, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global AI in Life Sciences Market Gearing Up for Outstanding Expansion at a CAGR of ~20% by 2034 | DelveInsight

New York, USA, May 13, 2026 (GLOBE NEWSWIRE) -- Global AI in Life Sciences Market Gearing Up for Outstanding Expansion at a CAGR of ~20% by 2034 | DelveInsight The AI in life sciences market is...
May 13, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

New York, USA, May 13, 2026 (GLOBE NEWSWIRE) -- Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight The...
May 12, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sepsis...
May 12, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight The HPV testing and Pap...